drugset / Trial / NCT06543550

Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis

NCT06543550

Phase 4 Recruiting 70 enrolled Bio Meds Pharmaceutica Ltda
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to evaluate the effects of therapy with implantable Gestrinone compared to oral Dienogest in relieving complaints related to endometriosis.

Timeline

Start
2024-07-30
Primary completion
2025-09
Completion
2025-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dienogest Small molecule 2 mg Oral
Subject Gestrinone Small molecule 1.6 mg/kg Subcutaneous

Indications